STAT+: Seven burning questions about the FDA’s post-Overton future

STAT tackles the most important questions about the FDA's uncertain future.
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk
Just in
Whistleblower's 'disturbing' allegations probed by Canberra Health Services
Just in

STAT+: The emerging winners and losers in the AI scribe market

Doctors learn of complaints through data leak from regulator

Anti-vaccine group once led by RFK Jr back on Facebook and Instagram after being banned

'Best night' of Dáithí's life all thanks to organ donation
